FindTrial
Sign In

Outcome Measures for Assessing the Effectiveness of Craniosacral Therapy for Migraine; A Pilot Single Center Randomized Controlled Trial.

the study of clinical efficacy and Mechanism for Craniosacral therapy on migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050264
Enrollment
Unknown
Registered
2021-08-24
Start date
2020-01-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Group A:Craniosacral therapy
Group B:complementary light-touch sham treatments

Sponsors

Yellow River Central Hospital of Yellow River Conservancy Commission
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18-60 years; 2. Meet ICHD 3rd edition criteria for migraine; 3. Headache frequency/month: 5–8; 4. Headache history > 2 years; 5. Accept treatment protocol; 6. Able to attend 2 weekly treatments; 7. Able to be evaluated once every four weeks.

Exclusion criteria

Exclusion criteria: 1. Serious depression, anxiety or psychosis; 2. Taking psychiatric medication within the previous 3month; 3. Major medical illness under treatment; 4. Pregnancy; 5. Clotting disorders; 6. Head or neck injury in the past 2 years; 7. History of skull, neck, and spine surgery; 8. Cardiac Pacemaker; 9. Head or neck implanted device (e.g. artery stent).

Design outcomes

Primary

MeasureTime frame
Headache Impact Test-6;Headache frequency;—

Countries

China

Contacts

Public ContactJiang Guangya

Yellow River Central Hospital of Yellow River Conservancy Commission

jiangguangya1009@126.com+86 13849090724

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026